Vindeca Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.95 M
- Revenue Growth -0.05%
- Profit Growth 36.98%
- Ebitda 40.29%
- Net Worth 37.15%
- Total Assets 31.14%
About Vindeca Life Sciences
Vindeca Life Sciences Private Limited (VLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 July 2010 and has a history of 14 years and seven months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.95 M.
Akhilesh Tripathi, Vikas Kumar, and Uday Nassa serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2010PTC205406
-
Company No.
205406
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jul 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Vindeca Life Sciences Private Limited offer?
Vindeca Life Sciences Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Dicloxacillin Capsules, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Who are the key members and board of directors at Vindeca Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akhilesh Tripathi
|
Director | 07-Jul-2010 | Current |
|
Vikas Kumar
|
Director | 07-Jul-2010 | Current |
|
Uday Nassa
|
Director | 07-Jul-2010 | Current |
Financial Performance of Vindeca Life Sciences.
Vindeca Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.05% decrease. The company also saw a substantial improvement in profitability, with a 36.98% increase in profit. The company's net worth Soared by an impressive increase of 37.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vindeca Life Sciences?
Unlock access to Vindeca Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Shaan Admark Consultant Private LimitedAkhilesh Tripathi is a mutual person
Charges (Loans)
₹0.95 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Feb 2021 | Axis Bank Limited | ₹0.95 M | Open |
How Many Employees Work at Vindeca Life Sciences?
Unlock and access historical data on people associated with Vindeca Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vindeca Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vindeca Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.